Latest Sedatives Stories
Sepracor Inc. (Nasdaq: SEPR) today announced the presentation of LUNESTA(R) brand eszopiclone Phase IV study data at the 21st European College of Neuropsychopharmacology (ECNP) Congress in Barcelona.
Somaxon Pharmaceuticals, Inc.
Novacea, Inc. (NASDAQ: NOVC) and Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that they have entered into a definitive merger agreement under which Novacea will merge with Transcept in an all-stock transaction.
SAN DIEGO, Aug. 18 /PRNewswire/ -- The next time you consider popping a pill when you have trouble nodding off, it might be worth counting sheep instead. A senior psychiatrist at the Scripps Clinic Sleep Center in San Diego, Calif.
Britain plans to outlaw two freely available chemicals that double as date-rape drugs, the country's domestic security and order office said.
Handa Pharmaceuticals has confirmed that its abbreviated new drug application for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR, has been accepted for filing by the FDA.
SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended June 30, 2008.
By HELEN PUTTICK HEALTH CORRESPONDENT A SCOTTISH GP who prescribed sleeping tablets to a patient so she could end her life should be struck off, a panel of the General Medical Council was told yesterday.
A GP who gave sleeping pills to an elderly patient so she could commit suicide said yesterday he "regretted the circumstances" which resulted in his censure by the General Medical Council.
WOODCLIFF LAKE, N.J., July 25 /PRNewswire/ -- Eisai Corporation of North America today announced that it has received a not approvable letter from the U.S.